| NP0350649 | ethyl lecanoate | |  | C18H18O7
346.3350 Da 346.10525 Da | |
| NP0350648 | 3-formyl lecanorin | |  | C16H14O6
302.2820 Da 302.07904 Da | |
| NP0350647 | lethardiphenylmethane E | |  | C17H18O6
318.3250 Da 318.11034 Da | |
| NP0350646 | lethardiphenylmethane D | |  | C20H22O8
390.3880 Da 390.13147 Da | |
| NP0350645 | lethardiphenylmethane C | |  | C21H24O8
404.4150 Da 404.14712 Da | |
| NP0350644 | lethardiphenylmethane B | |  | C20H22O8
390.3880 Da 390.13147 Da | |
| NP0350643 | lethardiphenylmethane A | |  | C21H24O8
404.4150 Da 404.14712 Da | |
| NP0350642 | Flavoaffinin 449 | |  | C29H23NO4
449.5060 Da 449.16271 Da | | 1H NMR Spectrum (1D, 600 MHz, C3D6O, experimental) | | 13C NMR Spectrum (1D, 151 MHz, C3D6O, experimental) | | [1H, 13C] NMR Spectrum (2D, 600 MHz, C3D6O, experimental) | | [1H, 13C] NMR Spectrum (2D, 600 MHz, C3D6O, experimental) | | [1H, 1H] NMR Spectrum (2D, 600 MHz, C3D6O, experimental) | | [1H, 1H] NMR Spectrum (2D, 600 MHz, C3D6O, experimental) |
|
| NP0350641 | Flavoaffinin 407 | |  | C27H21NO3
407.4690 Da 407.15214 Da | | 1H NMR Spectrum (1D, 600 MHz, C3D6O, experimental) | | [1H, 13C] NMR Spectrum (2D, 600 MHz, C3D6O, experimental) | | 13C NMR Spectrum (1D, 151 MHz, C3D6O, experimental) | | [1H, 1H] NMR Spectrum (2D, 600 MHz, C3D6O, experimental) | | [1H, 13C] NMR Spectrum (2D, 600 MHz, C3D6O, experimental) | | [1H, 1H] NMR Spectrum (2D, 600 MHz, C3D6O, experimental) | | [1H, 1H] NMR Spectrum (2D, 600 MHz, C3D6O, experimental) |
|
| NP0350640 | Contignasterine B | |  | C32H52N3O6
574.7820 Da 574.38506 Da | | [1H, 1H] NMR Spectrum (2D, 600 MHz, C2D6OS, experimental) | | [1H, 1H] NMR Spectrum (2D, 600 MHz, CD3OD, experimental) | | 1H NMR Spectrum (1D, 600 MHz, C2D6OS, experimental) | | 1H NMR Spectrum (1D, 600 MHz, CD3OD, experimental) | | [1H, 13C] NMR Spectrum (2D, 600 MHz, C2D6OS, experimental) | | [1H, 13C] NMR Spectrum (2D, 600 MHz, CD3OD, experimental) | | [1H, 13C] NMR Spectrum (2D, 600 MHz, C2D6OS, experimental) | | [1H, 13C] NMR Spectrum (2D, 600 MHz, CD3OD, experimental) | | [1H, 1H] NMR Spectrum (2D, 600 MHz, C2D6OS, experimental) |
|
| NP0350639 | Contignasterine A | |  | C32H52N3O9P
653.7540 Da 653.34412 Da | | 13C NMR Spectrum (1D, 151 MHz, C2D6OS, experimental) | | 13C NMR Spectrum (1D, 151 MHz, CD3OD, experimental) | | [1H, 1H] NMR Spectrum (2D, 600 MHz, C2D6OS, experimental) | | [1H, 1H] NMR Spectrum (2D, 600 MHz, CD3OD, experimental) | | 1H NMR Spectrum (1D, 600 MHz, C2D6OS, experimental) | | 1H NMR Spectrum (1D, 600 MHz, CD3OD, experimental) | | [1H, 13C] NMR Spectrum (2D, 600 MHz, CD3OD, experimental) | | [1H, 13C] NMR Spectrum (2D, 600 MHz, CD3OD, experimental) | | [1H, 1H] NMR Spectrum (2D, 600 MHz, C2D6OS, experimental) | | [1H, 1H] NMR Spectrum (2D, 600 MHz, CD3OD, experimental) |
|
| NP0350638 | N-AcCys-ansatrienin B | |  | C41H57N3O11S
799.9800 Da 799.37138 Da | | 1H NMR Spectrum (1D, 600.132933733, CD3OD, simulated) | | 1H NMR Spectrum (1D, 600 MHz, CD3OD, experimental) | | 1H NMR Spectrum (1D, 600 MHz, CD3OD, experimental) | | 1H NMR Spectrum (1D, 600 MHz, CD3OD, experimental) | | 13C NMR Spectrum (1D, 151 MHz, CD3OD, experimental) | | 13C NMR Spectrum (1D, 151 MHz, CD3OD, experimental) | | [1H, 1H] NMR Spectrum (2D, 600 MHz, CD3OD, experimental) | | [1H, 13C] NMR Spectrum (2D, 600 MHz, CD3OD, experimental) | | [1H, 13C] NMR Spectrum (2D, 600 MHz, CD3OD, experimental) | | [1H, 1H] NMR Spectrum (2D, 600 MHz, CD3OD, experimental) |
|
| NP0350637 | N-AcCys-ansatrienin 3a | |  | C39H55N3O11S
773.9400 Da 773.35573 Da | | 1H NMR Spectrum (1D, 500.071986512, CD3OD, simulated) | | 1H NMR Spectrum (1D, 500 MHz, CD3OD, experimental) | | 1H NMR Spectrum (1D, 500 MHz, CD3OD, experimental) | | [1H, 1H] NMR Spectrum (2D, 500 MHz, CD3OD, experimental) | | [1H, 1H] NMR Spectrum (2D, 500 MHz, CD3OD, experimental) | | [1H, 13C] NMR Spectrum (2D, 500 MHz, CD3OD, experimental) | | [1H, 13C] NMR Spectrum (2D, 500 MHz, CD3OD, experimental) | | 13C NMR Spectrum (1D, 126 MHz, CD3OD, experimental) | | 13C NMR Spectrum (1D, 126 MHz, CD3OD, experimental) |
|
| NP0350636 | trienomycin O | |  | C34H46N2O7
594.7490 Da 594.33050 Da | | 1H NMR Spectrum (1D, 600, CDCl3, simulated) | | 13C NMR Spectrum (1D, 151 MHz, CDCl3, experimental) | | 13C NMR Spectrum (1D, 151 MHz, CDCl3, experimental) | | 1H NMR Spectrum (1D, 600 MHz, CDCl3, experimental) | | [1H, 1H] NMR Spectrum (2D, 600 MHz, CDCl3, experimental) | | [1H, 13C] NMR Spectrum (2D, 600 MHz, CDCl3, experimental) | | [1H, 13C] NMR Spectrum (2D, 600 MHz, CDCl3, experimental) |
|
| NP0350635 | trienomycin N | |  | C36H50N2O7
622.8030 Da 622.36180 Da | | 1H NMR Spectrum (1D, 599.771213707, CD3OD, simulated) | | 1H NMR Spectrum (1D, 600 MHz, CD3OD, experimental) | | 13C NMR Spectrum (1D, 151 MHz, CD3OD, experimental) | | [1H, 1H] NMR Spectrum (2D, 600 MHz, CD3OD, experimental) | | 13C NMR Spectrum (1D, 151 MHz, CD3OD, experimental) | | [1H, 13C] NMR Spectrum (2D, 600 MHz, CD3OD, experimental) | | [1H, 13C] NMR Spectrum (2D, 600 MHz, CD3OD, experimental) | | [1H, 1H] NMR Spectrum (2D, 600 MHz, CD3OD, experimental) |
|
| NP0350634 | trienomycin M | |  | C36H50N2O8
638.8020 Da 638.35672 Da | | 1H NMR Spectrum (1D, 500.19300114, CD3OD, simulated) | | 1H NMR Spectrum (1D, 500 MHz, CD3OD, experimental) | | 1H NMR Spectrum (1D, 500 MHz, CD3OD, experimental) | | 1H NMR Spectrum (1D, 500 MHz, CD3OD, experimental) | | 13C NMR Spectrum (1D, 126 MHz, CDCl3, experimental) | | 13C NMR Spectrum (1D, 126 MHz, CD3OD, experimental) | | 13C NMR Spectrum (1D, 126 MHz, CD3OD, experimental) | | [1H, 1H] NMR Spectrum (2D, 500 MHz, CD3OD, experimental) | | [1H, 13C] NMR Spectrum (2D, 500 MHz, CD3OD, experimental) | | [1H, 13C] NMR Spectrum (2D, 500 MHz, CD3OD, experimental) | | [1H, 1H] NMR Spectrum (2D, 500 MHz, CD3OD, experimental) |
|
| NP0350633 | Euphpepluone S | |  | C25H34O6
430.5410 Da 430.23554 Da | | 1H NMR Spectrum (1D, 600, CDCl3, simulated) | | 1H NMR Spectrum (1D, 600 MHz, CDCl3, experimental) | | 13C NMR Spectrum (1D, 151 MHz, CDCl3, experimental) | | [1H, 1H] NMR Spectrum (2D, 600 MHz, CDCl3, experimental) | | [1H, 13C] NMR Spectrum (2D, 600 MHz, CDCl3, experimental) | | [1H, 13C] NMR Spectrum (2D, 600 MHz, CDCl3, experimental) | | [1H, 1H] NMR Spectrum (2D, 600 MHz, CDCl3, experimental) |
|
| NP0350632 | Euphpepluone R | |  | C25H34O6
430.5410 Da 430.23554 Da | | 1H NMR Spectrum (1D, 600, CDCl3, simulated) | | 1H NMR Spectrum (1D, 600 MHz, CDCl3, experimental) | | 13C NMR Spectrum (1D, 151 MHz, CDCl3, experimental) | | [1H, 1H] NMR Spectrum (2D, 600 MHz, CDCl3, experimental) | | [1H, 13C] NMR Spectrum (2D, 600 MHz, CDCl3, experimental) | | [1H, 13C] NMR Spectrum (2D, 600 MHz, CDCl3, experimental) | | [1H, 1H] NMR Spectrum (2D, 600 MHz, CDCl3, experimental) |
|
| NP0350631 | Pinoresinol-4, 4'-di-O-β-D-xylopyranoside | |  | C30H38O14
622.6200 Da 622.22616 Da | | 13C NMR Spectrum (1D, 151 MHz, C2D6OS, experimental) | | [1H, 1H] NMR Spectrum (2D, 600 MHz, C2D6OS, experimental) | | 1H NMR Spectrum (1D, 600 MHz, C2D6OS, experimental) | | [1H, 13C] NMR Spectrum (2D, 600 MHz, C2D6OS, experimental) | | [1H, 13C] NMR Spectrum (2D, 600 MHz, C2D6OS, experimental) | | [1H, 1H] NMR Spectrum (2D, 600 MHz, C2D6OS, experimental) |
|
| NP0350630 | Pinoresinol-4-O-β-D-xylopyranoside | |  | C25H30O10
490.5050 Da 490.18390 Da | | 13C NMR Spectrum (1D, 151 MHz, C2D6OS, experimental) | | [1H, 1H] NMR Spectrum (2D, 600 MHz, C2D6OS, experimental) | | 1H NMR Spectrum (1D, 600 MHz, C2D6OS, experimental) | | [1H, 13C] NMR Spectrum (2D, 600 MHz, C2D6OS, experimental) | | [1H, 13C] NMR Spectrum (2D, 600 MHz, C2D6OS, experimental) | | [1H, 1H] NMR Spectrum (2D, 600 MHz, C2D6OS, experimental) |
|
| NP0350629 | Wrightioside K | |  | C17H24O8
356.3710 Da 356.14712 Da | | 13C NMR Spectrum (1D, 151 MHz, C2D6OS, experimental) | | [1H, 1H] NMR Spectrum (2D, 600 MHz, C2D6OS, experimental) | | 1H NMR Spectrum (1D, 600 MHz, C2D6OS, experimental) | | [1H, 13C] NMR Spectrum (2D, 600 MHz, C2D6OS, experimental) | | [1H, 13C] NMR Spectrum (2D, 600 MHz, C2D6OS, experimental) |
|
| NP0350628 | Wrightioside J | |  | C20H30O10
430.4500 Da 430.18390 Da | | 13C NMR Spectrum (1D, 151 MHz, C2D6OS, experimental) | | [1H, 1H] NMR Spectrum (2D, 400 MHz, C2D6OS, experimental) | | 1H NMR Spectrum (1D, 600 MHz, C2D6OS, experimental) | | [1H, 13C] NMR Spectrum (2D, 600 MHz, C2D6OS, experimental) | | [1H, 13C] NMR Spectrum (2D, 600 MHz, C2D6OS, experimental) |
|
| NP0350627 | Wrightioside I | |  | C17H24O8
356.3710 Da 356.14712 Da | | 13C NMR Spectrum (1D, 151 MHz, C2D6OS, experimental) | | [1H, 1H] NMR Spectrum (2D, 600 MHz, C2D6OS, experimental) | | 1H NMR Spectrum (1D, 600 MHz, C2D6OS, experimental) | | [1H, 13C] NMR Spectrum (2D, 600 MHz, C2D6OS, experimental) | | [1H, 13C] NMR Spectrum (2D, 600 MHz, C2D6OS, experimental) | | [1H, 1H] NMR Spectrum (2D, 600 MHz, C2D6OS, experimental) |
|
| NP0350626 | Wrightioside H | |  | C16H22O7
326.3450 Da 326.13655 Da | | 13C NMR Spectrum (1D, 151 MHz, C2D6OS, experimental) | | [1H, 1H] NMR Spectrum (2D, 600 MHz, C2D6OS, experimental) | | 1H NMR Spectrum (1D, 600 MHz, C2D6OS, experimental) | | [1H, 13C] NMR Spectrum (2D, 600 MHz, C2D6OS, experimental) | | [1H, 13C] NMR Spectrum (2D, 600 MHz, C2D6OS, experimental) | | [1H, 1H] NMR Spectrum (2D, 600 MHz, C2D6OS, experimental) |
|
| NP0350625 | Wrightioside G | |  | C14H18O8
314.2900 Da 314.10017 Da | | 13C NMR Spectrum (1D, 151 MHz, C2D6OS, experimental) | | [1H, 1H] NMR Spectrum (2D, 600 MHz, C2D6OS, experimental) | | 1H NMR Spectrum (1D, 600 MHz, C2D6OS, experimental) | | [1H, 13C] NMR Spectrum (2D, 600 MHz, C2D6OS, experimental) | | [1H, 13C] NMR Spectrum (2D, 600 MHz, C2D6OS, experimental) | | [1H, 1H] NMR Spectrum (2D, 600 MHz, C2D6OS, experimental) |
|